Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

PLA2 inhibitors claimed by AHP for asthma, inflammatory conditions

May 24, 1996

Pseudostat clinical results in bronchiectasis

May 17, 1996

SKB's anti-IL-5 MAb in preclinical testing for asthma

May 17, 1996

NK1/NK2 antagonist MDL-105212: Potential antiasthmatic

May 17, 1996

Takeda claims NK1 ligands for respiratory indications

May 17, 1996

PDE IV inhibitor SB-207499 in phase II

May 17, 1996

Byk Gulden reports PDE IV inhibitors for asthma, dermatoses

May 17, 1996

Pentoxifylline claimed for treating cold symptoms

May 17, 1996

R-844: Novel steroid for asthma

May 10, 1996

Glaxo Wellcome's newest approach to ARDS

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.